Status:
COMPLETED
Transcranial Direct Current Stimulation Combined Sensory Modulation Intervention in Chronic Stroke Patients
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Stroke
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Background and purpose: About 30% of people with stroke suffered from severe long-term upper extremity （UE） motor impairment. Severe UE impairment, especially dysfunction of hand, can greatly impact ...
Eligibility Criteria
Inclusion
- first ever ischemic or hemorrhagic stroke patients identified by computed tomography (CT) or magnetic resonance imaging (MRI)
- age between 40 and 80 years old
- have a stroke over 6 months
- unilateral hemiplegia
- Fugl-Meyer assessment-upper extremity (FMA-UE) score≦29 when selection
- poststroke elbow flexor spasticity less than 2 using modified Ashworth scale (MAS)
- no severe anesthesia (FMA sensory test, upper extremity score≧10 )
- no wrist and finger joint pain
- clear consciousness, can understand simple sentences and spoken orders, and co-operate manipulation
- can accept motor training in the sitting position for approximately 30 minutes.
Exclusion
- Suffer from other orthopedic diseases (such as severe arthritis), nerve damage (such as peripheral nerve damage), or severe pain, which influences upper extremity motor
- have a medical history or family history of epilepsy
- regularly take central nervous system drugs (such as sedatives), or the Class III antiarrhythmic drugs (such as amiodarone)
- have atopic dermatitis or skin disorders of the scalp
- have allergy to anesthetic medicines of the acyl amine
- have a metal implant in the head or neck, or serious arrhythmia (the heartbeat is less than 50 beats per minute or higher than 100 beats per minute); or use a pacemaker or atrial defibrillator
- suffer from congenital or idiopathic methemoglobinemia. Aphasia is not an exclusion criterion, but the patients should understand simple spoken orders.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01847157
Start Date
January 1 2013
End Date
June 1 2015
Last Update
February 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100